Sutimlimab Moves to Phase 3 Trials: A New Potential Therapy for Cold Agglutinin Disease!
Cold agglutinin disease (CAD) occurs when the body's antibodies destroy their own red blood cells. It is a form of hemolytic anemia, meaning the body can't produce enough blood cells fast…